Weill Cornell Medical College
New York, 10065, United States
NCT Number: NCT00652210
Multiphoton microscopy (MPM) has been shown to be able to image tissue at a cellular level. Our project will initially evaluated the ability of MPM imaging to distinguish normal bladder urothelium from atypical and malignant urothelium in the ex vivo setting. After development of sufficient criteria, we plan to develop an endoscopic bladder probe that will provide a non-invasive means to image the interior of the bladder at the cellular level, which would provide direct evidence of the presence of tumor without a biopsy. After exhibiting usefulness of MPM imaging for bladder cancer, we will look at other organs beginning with the colon.
Looking for future studies?
Notify Me21 year–85 year
All sexes
Interventional
Phase 1
New York, 10065, United States
Same as above
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Use of multiphoton microscopy to diagnose cancer
Time frame: 10/14/2007 to 2/15/2008
Weill Medical College of Cornell University
Other
Acronym: MPM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06955910
Behavior, Behavioral Symptoms
Padova, Italy/Padova, Italy
View Trial DetailsNCT03345563
Bladder Cancer, Colon Cancer
New Brunswick, New Jersey, United States
View Trial DetailsNCT02704832
Adnexal Diseases, Bladder Cancer
Grenoble, Auvergne-Rhône-Alpes, France
View Trial DetailsNCT05253053
Adenocarcinoma, Advanced Solid Tumor
Wuhu, Anhui, China
View Trial Details